Berylson Capital Partners, LLC Ascendis Pharma A/S Transaction History

Berylson Capital Partners, LLC

$33.9 Million
Q3 2024

A detailed history of Berylson Capital Partners, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Berylson Capital Partners, LLC holds 1,900 shares of ASND stock, worth $246,639. This represents 0.83% of its overall portfolio holdings.

Number of Shares

1,900

Previous 1,900 -0.0%

Holding current value

$246,639

Previous $259,000 9.27%

% of portfolio

0.83%

Previous 0.64%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$121.07 - $153.67 $84,749 - $107,568	-700 Reduced 26.92%	1,900 $259,000
Q2 2023 Aug 14, 2023	SELL	$69.96 - $97.84 $769,559 - $1.08 Million	-11,000 Reduced 80.88%	2,600 $232,000
Q1 2023 May 15, 2023	BUY	$104.9 - $126.78 $1.43 Million - $1.72 Million	13,600 New	13,600 $1.46 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $4.29 Million - $5.62 Million	51,000 New	51,000 $5.27 Million
Q2 2022 Aug 15, 2022	SELL	$78.08 - $117.61 $3.08 Million - $4.63 Million	-39,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$102.18 - $135.75 $4.03 Million - $5.35 Million	39,400 New	39,400 $4.62 Million
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $7.92 Million - $12.4 Million	-70,300 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$121.62 - $145.29 $2.68 Million - $3.2 Million	-22,025 Reduced 23.86%	70,300 $9.25 Million
Q1 2021 May 17, 2021	BUY	$124.92 - $173.33 $2.45 Million - $3.4 Million	19,625 Added 26.99%	92,325 $11.9 Million
Q3 2020 Nov 16, 2020	BUY	$134.29 - $154.32 $1.95 Million - $2.24 Million	14,500 Added 24.91%	72,700 $11.2 Million
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $6.45 Million - $9.08 Million	58,200 New	58,200 $8.61 Million
Q2 2019 Aug 14, 2019	SELL	$107.11 - $132.09 $889,013 - $1.1 Million	-8,300 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $515,845 - $1.08 Million	8,300 New	8,300 $977,000

Others Institutions Holding ASND

# of Institutions

243

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.24B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berylson Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berylson Capital Partners, LLC with notifications on news.

Account

Berylson Capital Partners, LLC Ascendis Pharma A/S Transaction History